Author Archives: Patient Advocate

Hello advocates! We need you and your voice to help continue the momentum for change in Washington, DC. In order to do this, we’re looking for an advocate (or two!) in all fifty states. Willing to help? Please let us know where you live and the names of your elected representatives. Find your elected representativesContinue reading “Advocates Across the US: An advocate in all 50 States Challenge!”

Hello, The Latest News in Herpes Advocacy is here. Enjoy reading the latest news? Want to see progress faster? Support our work today. Healthy Volunteers Needed for BNT163-01 Clinical Trial Healthy volunteers sought for clinical trial for herpes vaccine candidate from BioNtech BNT-163-01. Volunteers needed near The University of Pennsylvania Hospital in Philadelphia, PA. This isContinue reading “Updates from the Pipeline, IHW 2023 and more news!”

Advocates Town Hall Meeting: Herpes advocates town hall meetings are open to patients, professionals, and those looking to get involved to make a difference. We’ll discuss Herpes Cure Advocacy urgent priorities, a 90 day action plan for new advocates, and ways to get more involved. Please submit questions in advance at info@herpescureadvocacy.com. Thursday, June 1Continue reading “Register: Herpes Advocates Town Hall Meeting June 1”

Herpes Clinical Pipeline AiCuris Non-Confidential Slide Deck May 2023: AiCuris planning for commercial launch of Priteliver 2025. Launch prep for Priteliver is ongoing. Innovative Molecules advances IM-250: The clinical trial center in Heidelberg, Germany has Phase 2 clinical trials are scheduled for 2024. The clinical phase 1 study investigates the safety, tolerability, and pharmacokinetics ofContinue reading “Progress for a Cure for Herpes Continues”

BDGene Therapeutics is a Chinese biotech company based in Shanghai. BDgene now has approval to run Phase 3 trials (held in China) on their gene therapy cure for HSV-1 keratitis. The gene editing treatment for viral keratitis (BD111), developed based on BDmRNA delivery patent technology, has completed 3 human clinical trials of IIT. It isContinue reading “Herpes Keratitis Cure advances to Phase 3 Clinical Trials in China”

Herpes Cure Advocacy celebrates a step forward on the path to the cure, treatment and prevention of Herpes. NIH has assembled a Multi-Council Working Group for Herpes Simplex Virus and are calling for input from field scientists and the general public. Herpes patients and field experts are excited to see this progress, an important winContinue reading “NIH forms Multi-Council Working Group for Herpes”

Herpes Cure Advocacy News HHS Listening Sessions: Two listening sessions were held this past week in an effort to gather insights for an addendum to the HHS 2020 STI Strategic Plan. Both patients and providers spoke with OIDP, NIH, and CDC stakeholders about their experiences and ideas for how to help cure, treat and preventContinue reading “Latest Updates on Herpes Cure Treatment and Prevention”

Mark your calendars! The HHS Office of Infectious Disease and HIV/AIDS Policy (OIDP) wants to hear from members of the STI community during two virtual listening sessions on April 4th and April 6th, 2023. OIDP is developing an addendum to the STI National Strategic Plan to include herpes simplex virus (HSV) types 1 and 2 in the United States.Continue reading “Advocacy Alert: Registration Open for OASH Listening Sessions”